Cargando…

On cribriform prostate cancer

The management of newly diagnosed prostate cancer is challenging because of its heterogeneity in histology, genetics and clinical outcome. The clinical outcome of patients with Gleason score 7 prostate cancer varies greatly. Improving risk assessment in this group is of particular interest, as Gleas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kweldam, Charlotte F., van der Kwast, Theodorus, van Leenders, Geert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861292/ https://www.ncbi.nlm.nih.gov/pubmed/29594028 http://dx.doi.org/10.21037/tau.2017.12.33

Ejemplares similares

Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
por: Böttcher, René, et al.
Publicado: (2018)

Automated detection of cribriform growth patterns in prostate histology images
por: Ambrosini, Pierre, et al.
Publicado: (2020)

Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies
por: Rijstenberg, L Lucia, et al.
Publicado: (2022)

Grading of prostate cancer: a work in progress
por: Kweldam, C F, et al.
Publicado: (2018)

Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern
por: van der Slot, Margaretha A., et al.
Publicado: (2022)

Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens
por: Rijstenberg, L. Lucia, et al.
Publicado: (2020)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens
por: Hollemans, Eva, et al.
Publicado: (2019)

Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome
por: van der Slot, Margaretha A., et al.
Publicado: (2020)

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
por: Hollemans, Eva, et al.
Publicado: (2020)

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis
por: Hollemans, Eva, et al.
Publicado: (2018)

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy
por: Hollemans, Eva, et al.
Publicado: (2020)

Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2017)

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
por: Seyrek, Neslisah, et al.
Publicado: (2021)

Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy
por: Seyrek, Neslisah, et al.
Publicado: (2022)

The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
por: van Leenders, Geert J.L.H., et al.
Publicado: (2020)

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
por: Böttcher, René, et al.
Publicado: (2015)

A distinct repertoire of cancer‐associated fibroblasts is enriched in cribriform prostate cancer
por: Hesterberg, Amanda B, et al.
Publicado: (2021)

Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance
por: Destouni, Maria, et al.
Publicado: (2022)

Cribriform ulcerations of the back
por: Aivaz, Marudeen, et al.
Publicado: (2020)

Progressive cribriform and zosteriform hyperpigmentation
por: Gutte, Rameshwar M.
Publicado: (2014)

Cribriform-morular variant of thyroid carcinoma
por: Cameselle-Teijeiro, J.M., et al.
Publicado: (2019)

Primary Cutaneous Cribriform Apocrine Carcinoma
por: Boettler, Michelle, et al.
Publicado: (2021)

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
por: Kamdar, Shivani, et al.
Publicado: (2019)

Are we ready to include invasive cribriform and intraductal carcinoma into the prostate cancer grade grouping system?
por: Xiao, Guang-Qian, et al.
Publicado: (2020)

Cribriform pattern in prostate tissues: Predictor for intraductal carcinoma of the prostate based on biopsy and radical prostatectomy pathology
por: Shiomi, Ei, et al.
Publicado: (2022)

Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease
por: Wong, Hong Yuen, et al.
Publicado: (2022)

Prostate Cancer Morphologies: Cribriform Pattern and Intraductal Carcinoma Relations to Adverse Pathological and Clinical Outcomes—Systematic Review and Meta-Analysis
por: Osiecki, Rafał, et al.
Publicado: (2023)

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
por: Rodríguez-Blanco, Giovanny, et al.
Publicado: (2018)

Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading
por: van Leenders, Geert J L H, et al.
Publicado: (2020)

An Updated Review of Cribriform Carcinomas with Emphasis on Histopathological Diagnosis and Prognostic Significance
por: Branca, Giovanni, et al.
Publicado: (2017)

Diagnostic performance of a nomogram incorporating cribriform morphology for the prediction of adverse pathology in prostate cancer at radical prostatectomy
por: Wang, Baojun, et al.
Publicado: (2020)

Post‐radiotherapy cribriform‐morular thyroid carcinoma
por: Or Koca, Arzu, et al.
Publicado: (2022)

Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island Microarrays
por: Kron, Ken, et al.
Publicado: (2009)

A Cribriform Cancer Metastatic to Liver: Case Report and Literature Review
por: Gupta, Annu, et al.
Publicado: (2019)

Distinct Adverse Clinical Outcomes of Small and Large Cribriform Patterns on Gleason 7 Prostate Cancer: A Preliminary Study
por: Kazan, Ozgur, et al.
Publicado: (2023)

Vitamin D(3) suppresses morphological evolution of the cribriform cancerous phenotype
por: Deevi, Ravi K., et al.
Publicado: (2016)

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
por: Venderbos, Lionne D. F., et al.
Publicado: (2015)

Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse
por: Fraser, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5nrr4u1f6e3lgsqpnia93phqfo